Similar articles

• A new chemotherapeutic agent: deoxycoformycin (pentostatin).

  Dillman RO. Dillman RO. Semin Hematol. 1994 Jan;31(1):16-27. Semin Hematol. 1994. PMID: 8122134 Review. No abstract available.
• Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

  Brogden RN, Sorkin EM. Brogden RN, et al. Drugs. 1993 Oct;46(4):652-77. doi: 10.2165/00003495-199346040-00006. Drugs. 1993. PMID: 7506651 Review.
• Pentostatin for the treatment of indolent lymphoproliferative disorders.

  Ho AD, Hensel M. Ho AD, et al. Semin Hematol. 2006 Apr;43(2 Suppl 2):S2-10. doi: 10.1053/j.seminhematol.2005.12.005. Semin Hematol. 2006. PMID: 16549110 Review.
• Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.

  Tallman MS, Hakimian D. Tallman MS, et al. Blood. 1995 Oct 1;86(7):2463-74. Blood. 1995. PMID: 7670093 Review. No abstract available.
• Pharmacology of purine nucleoside analogues.

  Plunkett W, Gandhi V. Plunkett W, et al. Hematol Cell Ther. 1996 Dec;38 Suppl 2:S67-74. Hematol Cell Ther. 1996. PMID: 9137959 Review.